Cetilistat T3283
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Cetilistat is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes.
CAS nr:
282526-98-1
Purity:
98%
Molecular Weight:
401,58
SMILES:
CCCCCCCCCCCCCCCCOc1nc2c(cc(cc2)C)c(=O)o1
Formula:
C25H39NO3
Pathway:
Metabolism
Target:
Lipid
